This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancerAstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung...
USFDA grants nod for Amgen Uplizna as first treatment for rare immune disorderUSFDA grants nod for Amgen Uplizna as first treatment for rare immune disorder
Natco Pharma sees major leadership exit in RnD, demand & supply, qualityNatco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs...
Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European MarketShilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu
Novo Nordisk reshapes Executive management teamNovo Nordisk reshapes Executive management team
Bayer Nubeqa gets EU approvalBayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced...
Zydus Desidustat Gets Expert Panel Nod for Phase-III Trial in Cancer-Related AnemiaZydus Lifesciences gets CDSCO panel nod to conduct bioequivalence study of Eltrombopag for oral...
NPPA Sets New Retail Price for Cilnidipine, Telmisartan CombinationNPPA Fixes Ceiling Price of Ringer Lactate Injection
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III TrialNovartis receives USFDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA...
Martin A. Makary sworn in as FDA CommissionerMartin A. Makary sworn in as FDA Commissioner
AbbVie seeks USFDA nod for combination regimen of Venclexta, AcalabrutinibUSFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases
Sanofi to expand respiratory vaccines pipeline with acquisition of VicebioLupin UK arm acquires Renascience Pharma for over Rs 138 crore
X